Relationship between Plasma Fibrinolytic Activity and Serum Fibrinogen Degradation Products (FDP) Tested by Various Methods

Summary

It was found in the present work that the level of serum fibrinogen degradation products (FDP) determined by the immunoassay method correlated well with the staphylococcal clumping titer in serum (correlation coefficient r = 0.68). The content of FDP in serum of 30 healthy subjects and patients with various diseases did not correlate, however, neither with blood fibrinolytic activity estimated by the euglobulin clot lysis time, nor with fibrinogen content and plasma anticlotting activity. It is concluded, that FDP appear in circulation as a result of local proteolytic degradation of intravascularly deposited fibrin without generalized activation of fibrinolysis.

• References

• 1 Astrup T. The hemostatic balance. Thrombos. Diathes. haemorrh. (Stuttg) 02: 347 1958;
• 2 Astrup T. The biological significance of fibrinolysis. Lancet II: 565 1956;
• 3 Copley A. L. Thrombosis and thromboembolization in blood capillaries. In: Internt. Conf. on Thrombos. Embolism. 452 Benno Schwabe; Basel: 1954
• 4 Goldenfarb P. B, Zucker S, Garrigan J. J, Cathey M. H. The coagulation mechanism in acute bacterial infection. Brit. J. Haemat 18: 643 1970;
• 5 Holemans R, Tysinger M. F. Site of origin of increased fibrinolytic activity during venous occlusion. Proc. Soc. exp. Biol. (N. Y) 118: 488 1965;
• 6 Kopec M, Wegrzynowicz Z, Latallo Z. S. Soluble fibrin complexes and a new specific test for their detection. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl 39: 219 1970;
• 7 Kowalski E, Kopec M, Niewiarowski S. An evaluation of the euglobulin method for determination of fibrinolysis. J. clin. Path 12: 215 1959;
• 8 Lipinski B. Detection of hypercoagulable states with protamine sulphate tests. Acta Carolinae Universitatis, Medica. (In press.)
• 9 Lipinski B, Hawiger J, Jeljaszewicz J. Staphylococcal clumping with soluble fibrin monomer complexes. J. exp. Med 126: 979 1967;
• 10 Lipinski B, Jeljaszewicz J. A hypothesis for the pathogenesis of the generalized Shwartz- manreaction. J. Infect. Dis 120: 160 1969;
• 11 Merskey C, Kleiner G. J, Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 28: 1 1966;
• 12 Niewiarowski S, Lipinski B. Staphylococcal clumping factor and other paracoagulating agents. Their application to the detection of fibrinogen derivatives. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl 39: 235 1970;
• 13 Quick A. J. The physiology and pathology of haemostasis. Kimpton; London: 1951
• 14 Sharp A. A, Warren B. A, Pexton A. M, Allington M. J. Anticoagulant therapy with a purified fraction of Malayan pit viper venom. Lancet I: 493 1968;
• 15 Snedecor G. W. Statistical Methods, Ames. 1956
• 16 Thuot C, Larrieu M. J. Fibrinogen degradation products: A critical study of two assy methods. Rev. Europ. Études Clin et Biol 16: 27 1971;
• 17 Worowski K, Niewiarowski S, Prokopowicz J. Fibrinolysis and fibrinogen breakdown products (Antithrombin VI) in renal venous dogs blood. Thrombos. Diathes. haemorrh. (Stuttg) 12: 87 1964;